Form 4: Director Ralph David Kelly Receives Acadia Healthcare Stock

Director Ralph David Kelly acquired 6,331 shares of Acadia Healthcare Company, Inc. common stock as part of an equity grant.

Summary

• Director Ralph David Kelly was granted 6,331 shares of Acadia Healthcare (ACHC) common stock on May 6, 2026.
• The shares were acquired at a price of $0.0, representing an equity compensation grant.
• Following this transaction, the director's total beneficial ownership increased to 26,358 shares.
• The granted shares are subject to a 3-year vesting schedule with equal annual installments starting May 6, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increased total beneficial ownership by the director to 26,358 shares.

Negatives

• None identified; this is a standard equity compensation disclosure.

Risks

• None identified; this is a standard equity compensation disclosure.

Future Outlook

The shares will vest in equal annual installments over a 3-year period, beginning May 6, 2027.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to align director incentives with long-term shareholder value in the healthcare services sector.

Comparison to Industry Standards

• The use of multi-year vesting schedules for director equity is consistent with standard corporate governance practices among S&P 400 and healthcare sector peers.

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the first installment of shares on May 6, 2027.

Key Dates

Keywords

Acadia Healthcare, ACHC, Form 4, Insider Trading, Director Compensation, Equity Grant